Search Results

0 results for 'Novo Nordisk'

You can use to get even better search results
March 15, 2024 | The Legal Intelligencer

Don't Be Cranky and Don't Cause Delays: Judge Pushes for Efficiency in Ozempic MDL

"What I want is to avoid asking for continuances and asking for delay and asking for new dates. Just pick your poison and stick with it," Pratter told the approximately 70 people gathered in her courtroom Thursday.
4 minute read
February 20, 2024 | New York Law Journal

Yes, Deal Activity is Surging. But How Long Will It Last?

Kirkland & Ellis, Latham & Watkins, Skadden, Arps, Slate, Meagher & Flom and other law firms with large transactional practices may see the recent rush of deals as the sign they've been waiting for. The Global Lawyer suggests they may want to curb their enthusiasm.
9 minute read
February 20, 2024 | The American Lawyer

Deals Are Back. But Don't Get Too Excited

Firms with large transactional practices may see the recent rush of deals as the sign they've been waiting for. The Global Lawyer suggests they may want to curb their enthusiasm.
8 minute read
February 18, 2024 | Law.com

Deals Are Back. But Don't Get Too Excited

Kirkland & Ellis, Latham & Watkins, Skadden, Arps, Slate, Meagher & Flom and other law firms with large transactional practices may see the recent rush of deals as the sign they've been waiting for. The Global Lawyer suggests they may want to curb their enthusiasm.
9 minute read
February 12, 2024 | The American Lawyer

Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars

Energy and life sciences continue to lead the way in deal activity, but tech and other recently nascent sectors are showing signs of life.
12 minute read
February 09, 2024 | New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read
February 09, 2024 | Law.com

Judges in the Hot Seat Over Oral Argument Diversity Policies

Three federal judges have standing orders that offer additional argument time for younger, women and minority attorneys to encourage greater participation from those groups.
6 minute read
February 09, 2024 | Litigation Daily

Litigator of the Week Runners-Up And Shout Outs

A team at Pillsbury Winthrop Shaw Pittman secured a ruling eliminating more than a half billion dollars in potential liability for client Teck Cominco Metals in a long-running environmental suit in the Eastern District of Washington.
7 minute read
February 08, 2024 | The American Lawyer

US Firms Line Up Behind $16B Three-Way Drug Manufacturing Deal

Skadden, Goodwin Procter and Jones Day are behind the $16.5 billion acquisition of an American pharmaceutical company by the holding company of Novo Nordisk, maker of weight-loss drug Wegovy and Type 2 diabetes shot Ozempic.
3 minute read

TRENDING STORIES

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now